Objective: The gastrointestinal hormones, gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1), are both released from the gut after oral glucose ingestion and stimulate insulin secretion. This study examined the release of these hormones in subjects with impaired glucose tolerance (IGT), which precedes the development of non-insulin-dependent diabetes. Design and methods: Six postmenopausal women with IGT, aged 59 years, underwent a 75 g oral glucose tolerance test and plasma levels of GIP and GLP-1 were determined regularly during the following 2 h. The results were compared with those in seven age-and weight-matched women with normal glucose tolerance (NGT). Results: Basal plasma levels of GIP and GLP-1 were not different between the groups. In response to the oral glucose ingestion, plasma levels of both GIP and GLP-1 increased in both groups. The plasma GIP increase after glucose ingestion was, however, reduced in women with IGT. Thus, the GIP response as determined as the area under the curve for the 60 min after oral glucose was 34.8 Ϯ 3.2 pmol/l per min in women with IGT versus 56.4 Ϯ 7.8 pmol/l per min in those with NGT (P ¼ 0.021). In contrast, the GLP-1 response to oral glucose was not different between the groups. By definition, the glucose response to oral glucose was markedly increased in women with IGT, and the insulin response during the second hour after glucose ingestion was exaggerated.
Introduction
The plasma insulin response following ingestion of glucose is higher when compared with that obtained by intravenous infusion of glucose eliciting the same blood glucose concentrations (1) . This potentiation of insulin secretion is due to the action of gut hormones, so called incretins, released during the oral glucose ingestion (2) . Several previous studies have shown that gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1), which are released from the gut during meal intake and stimulate insulin secretion at concentrations which circulate postprandially, are the major incretin hormones (2) (3) (4) (5) (6) . GIP is produced in the K cells in the duodenum whereas GLP-1 is produced in the L cells in the distal portion of the small intestine (2, 5) .
It has been demonstrated that impaired glucose tolerance (IGT) is a condition associated with an increased risk for developing non-insulin-dependent diabetes mellitus (NIDDM) (7) (8) (9) (10) . Several recent studies have shown that subjects with IGT exhibit islet dysfunction (11) (12) (13) . Based on studies in a large number of individuals, we recently suggested that insulin secretion is inadequately increased to compensate for the accompanying insulin resistance in IGT (14) . One tentative mechanism underlying this impaired insulin secretion in IGT is impaired release or action of the gut hormones which participate in the regulation of insulin secretion, i.e. GIP and GLP-1. In NIDDM, basal plasma GIP levels have been shown to be unaltered when compared with healthy controls (15) . In contrast, whether stimulated GIP release is affected in NIDDM is controversial, since some studies have demonstrated impaired response to meal stimulus or oral glucose (16) (17) (18) , whereas other studies have reported exaggerated responses (15) . Similarly, the GLP-1 response to meal ingestion or oral glucose in NIDDM is controversial, since both impaired (18) and potentiated (19) responses have been reported. However, whether abnormal GIP or GLP-1 secretion exists in IGT is not known. We have therefore, in this study, examined the GIP and GLP-1 plasma responses to an oral glucose load in a homogenous group of postmenopausal women with IGT in comparison with an age-and weight-matched control group with normal glucose tolerance (NGT). The study was undertaken in subjects of the same sex, to avoid the previously described sexdependent difference in gastric emptying (20) (21) (22) , and we studied women of an age group with a high preponderance of IGT and thereby an increased risk for the development of NIDDM (23) .
Subjects and methods

Subjects
We studied 13 postmenopausal women aged 59 years (mean Ϯ S.D. 59 years 2 monthsϮ6 months). According to a 75 g oral glucose tolerance test using WHO criteria (24) seven of the subjects had NGT, whereas six subjects had IGT. All subjects had normal liver and thyroid function tests and none was taking any medication known to affect glucose tolerance. All subjects received oral and written information concerning the aims and methods of the study, and signed a consent declaration before the start of the study. The study protocol was approved by the Ethics Committee of Lund University.
Study protocol
Following an overnight fast, an intravenous cannula was inserted into one antecubital vein. Two baseline samples were then taken, whereafter 75 g glucose dissolved in 250 ml water was ingested. Thereafter, blood samples were taken every 15 min for 120 min. The subjects spent the 2 h in a semi-recumbent position, and were not allowed to smoke during the test.
Analyses
Blood samples were immediately centrifuged at 5 ЊC and serum or plasma frozen at ¹20 ЊC until analysis. Serum insulin concentrations were analysed with a doubleantibody RIA technique. Guinea-pig anti-human insulin antibodies, human insulin standard and mono-125 I-tyr-labelled human insulin tracer (Linco Res. Inc., St Charles, MO, USA) were used. Samples for analysis of GIP and GLP-1 were obtained in prechilled test tubes containing EDTA (2.8 mmol/l blood; Sigma Chemical Co., St Louis, MO, USA) and aprotinin (250 KIU/ml blood; Bayer AG, Leverkusen, Germany). Analyses of GIP concentrations were performed with a double-antibody RIA technique using rabbit anti-human GIP antibodies (R65), 125 I-labelled human GIP and human GIP standard (25) . The antibody employed cross-reacts fully with human GIP, but not with socalled 8 kDa GIP, the nature and relationship of which to the synthesis or secretion of GIP is still unclear (26, 27) . Plasma concentrations of GLP-1 were measured with an RIA after extraction with ethanol as previously described (28) . The antiserum (code no. 89390) is directed against the amidated C-terminus of GLP-1 and therefore mainly measures GLP-1 of intestinal origin. Plasma glucose concentrations were determined using the glucoseoxidase method. All samples of glucose, insulin, GIP and GLP-1 were analysed in duplicate, and the mean values for each time-point are given in the Results.
Calculations and statistics
Data are presented as meanϮS.E. unless otherwise noted. Statistical analyses were performed with the SPSS for Windows system (29) . The areas under the curve for the supra-basal GIP and GLP-1 levels were calculated by the trapezoid rule. Differences between subjects with NGT versus those with IGT were evaluated with the MannWhitney U test for unrelated samples. Table 1 shows that subjects with IGT had higher fasting insulin levels than those with NGT (P ¼ 0.015), whereas the fasting glucose, GIP and GLP-1 levels did not differ significantly between the two groups. Figure 1 shows that following the oral ingestion of 75 g glucose, glucose levels rose to a peak level of 7.2 Ϯ 0.4 mmol/l at 30 min in subjects with NGT, whereafter they gradually returned to fasting levels. In contrast, in subjects with IGT, glucose levels increased markedly to the peak of 10.1 Ϯ 0.5 mmol/l, which was reached at 90 min. Serum insulin increased by the same pattern and degree in the two groups until 75 min, whereafter it declined in subjects with NGT, but continued to increase in subjects with IGT. At 120 min, serum insulin was 270 Ϯ 43 pmol/l in NGT versus 535 Ϯ 125 pmol/l in IGT (P ¼ 0.015).
Results
Plasma GIP increased sharply in subjects with NGT and had already reached its peak level of 80.1 Ϯ 12.2 pmol/l at 15 min after ingestion of glucose. Plasma GIP was thereafter stable at this elevated level, until 90 min, whereafter it fell slowly. Also in subjects with IGT, plasma GIP increased markedly and had already reached a level of 64.8 Ϯ 7.7 pmol/l at 15 min. The area under the curve for the 60 min after the glucose challenge of the supra-basal GIP levels was lower in the subjects with IGT (34.8 Ϯ 3.2 pmol/l per min) than in the women with NGT (56.4 Ϯ 7.8 pmol/l per min; P ¼ 0.021). The absolute GIP levels were significantly lower in women with IGT than in women with NGT at 15, 30 and 60 min after oral glucose ingestion (P < 0.05). Also plasma GLP-1 increased after oral glucose ingestion, with a peak level being seen after 30 min. After 30 min, plasma GLP-1 slowly decreased with no difference between the two groups. The increase in plasma GLP-1 was not different between the groups with IGT and NGT, since the area under the curve for the 60 min after the oral glucose was 10.7 Ϯ 0.6 pmol/l per min in women with IGT versus 11.5 Ϯ 0.8 pmol/l per min in those with NGT (not significant).
Discussion
The subjects with IGT in the present study had slightly increased basal serum insulin levels as a sign of reduced insulin sensitivity. They had also, by definition, a markedly elevated plasma glucose response to the glucose ingestion and this was accompanied by continuously increasing serum insulin levels during the second hour after glucose ingestion. It has previously been shown that IGT is accompanied by islet dysfunction, manifested as an inadequate insulin secretion for the prevailing glucose level (11) (12) (13) (14) . The mechanism for this inadequate insulin response has not been established. One tentative explanation is impaired release or action of gut hormones with incretin activity, mainly GIP and GLP-1 (2-6). Both impaired and potentiated GIP and GLP-1 responses to meal ingestion or oral glucose in NIDDM have been reported (15) (16) (17) (18) (19) . In IGT accompanying liver cirrhosis and Turner syndrome, GIP responses to oral glucose have been shown to be impaired (30, 31) , whereas a normal GIP response has been found in subjects with IGT and cystic fibrosis (32) . However, no earlier study has examined the GIP and GLP-1 responses to oral glucose in otherwise healthy postmenopausal women with IGT. Therefore, it was not known whether abnormal release of the major incretin hormones might accompany the islet dysfunction which we previously demonstrated in this group (12, 14) . We thus examined the GIP and GLP-1 responses to oral glucose in a homogenous group of postmenopausal women belonging to a population with a prevalent degree of IGT (23) . Also, we selected women for the study to avoid the well-known sex influence of gastric emptying (20) (21) (22) .
Our results show that plasma GIP had already increased at 15 min after glucose ingestion, and that a raised plasma GIP level persisted throughout the 120-min study period. This confirms the recent study of Schirra and collaborators (33) , showing that plasma GIP remained elevated for 180 min after oral glucose ingestion. This pattern of plasma GIP is compatible with the view that it is the absorption of glucose in the duodenum that governs GIP release, rather than simply the presence of glucose intraduodenally (34, 35) . Our main finding, however, is that the GIP response to oral glucose was reduced in IGT. This was evident during the first hour after glucose ingestion. Since the glucose response was enhanced, the mechanism for the impaired GIP release was apparently not due to lower glucose absorption. It has previously been reported in rats that insulin inhibits GIP secretion (36) . Therefore, a tentative explanation for the reduced GIP response to oral glucose in IGT could be an exaggerated insulin response. However, the increase in serum insulin during the first 15 min did not differ between the two groups, whereas plasma GIP was lower in women with IGT than in those with NGT at 15 min after glucose ingestion. This suggests that insulin-induced inhibition of GIP release does not account for the lower GIP response in this group, at least during the first 15 min after oral glucose.
Plasma GLP-1 increased rapidly after oral glucose ingestion in our study and peaked after 30 min. Thereafter, plasma GLP-1 fell towards fasting values. The rapid GLP-1 release after oral glucose ingestion confirms previous studies (3-5, 15, 33) . Since GLP-1 is produced mainly in the distal portion of the small intestine, it has been suggested that the rapid GLP-1 secretion following oral glucose is induced not by luminal stimulation of the GLP-1-producing L cells, but rather by hormonal or neural mechanisms initiated by oral glucose (37 has been suggested to be one such mechanism, since GIP has been demonstrated to stimulate GLP-1 release in rats (38) , although such an effect has not been observed in humans (18) . However, we found no correlation between plasma GIP and plasma GLP-1 in our study, suggesting that other mechanisms are of greater importance for GLP-1 secretion in humans. We found that plasma GLP-1 did not differ between subjects with NGT versus those with IGT, neither in the basal state nor after glucose ingestion. Therefore, it is unlikely that altered GLP-1 secretion contributes to impaired insulin secretion in IGT.
In conclusion, we have shown that during an oral glucose tolerance test, the plasma GIP response is reduced in postmenopausal women with IGT, whereas the plasma GLP-1 response is not different from controls with NGT.
